Hi authur,i know you have been a sceptic of SBP for a long time now.
The company i beleive is clearly moving forward on two fronts of human trials.I have always been a supporter but i have always beat on the management for the lack of promotion of the company.
I think the drug has an enormous amount of potential and the results are getting better the further they get into the trials.
These last results that sent the stock for a powerful run,i know were on mice.People still are sceptics.I have to say that i have been driven from the start from the Special Acces Scheme results on terminal people.I have been there for a long time now even when it was BNA.I will continue to be there till the full potential of their drug is realised.
I think that this drug if it dosnt stand on its own will definatley be used in a combination type of therapy.
Good luck to those who have held in there,its been a long journey.I think 2005 should be a very interesting and hopefully a serious rerating of the stock will be acheived as they proceed with phase 2 trials.
SBP Price at posting:
0.0¢ Sentiment: LT Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
